Denis Ribon

Denis Ribon is the current Chairman & Managing Partner at ArchiMed. Denis has also previously served as a Board Director for Provepharm Life Solutions and Citieffe Holding.

Ribon began their career working for Prollenium, a company specializing in advanced medical devices. Denis then transitioned to SUANFARMA, a pharmaceutical company focused on developing new drugs and treatments. After several years with SUANFARMA, Denis moved to ImaBiotech, a diagnostics company that provides personalized medicine solutions.

In 2010, Denis became the CEO of NAMSA, a global contract research organization. Denis then joined ActiGraph as the President & CEO in 2012. In 2014, Denis became a Board Director for Polyplus-transfection S.A. and Citieffe Holding. Denis returned to ArchiMed in 2018 as the Chairman & Managing Partner.

Denis Ribon attended VetAgro Sup, where they studied Veterinary, and then HEC Paris for their Master of Business Administration (MBA). Denis also has a Baccalauréat in Mathematics from Sainte-Marie Lyon.

André - Michel Ballester - Managing Partner, Justin Bateman - Partner, and Christoph Böhmer - Operating Partner report to Denis Ribon.